Literature DB >> 20622515

The role of CELF proteins in neurological disorders.

Jean-Marc Gallo1, Carl Spickett.   

Abstract

CELF (CUG-BP and ETR-3-like factors) proteins are structurally related RNA-binding proteins involved in various aspects of RNA processing including splicing and mRNA stability. The first member of the family, CELF1/CUG-BP1, was identified through its role in myotonic dystrophy, type 1. Several recent studies have uncovered the recurrent implication, to various extents, of CELF proteins or of the functionally related muscleblind-like 1 protein in a number of neurological conditions. This is particularly clear for inherited neurodegenerative disorders caused by expansions of translated or untranslated triplet repeats in the causative gene. Here we review the role played by CELF proteins, at least as modifiers of the pathological phenotype, in a number of neurological diseases. The involvement of CELF proteins suggest that individual pathogenic pathways in a number of neurological conditions overlap at the level of RNA processing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622515      PMCID: PMC3062235          DOI: 10.4161/rna.7.4.12345

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  71 in total

1.  CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing.

Authors:  Andrea N Ladd; Nicole H Nguyen; Kavin Malhotra; Thomas A Cooper
Journal:  J Biol Chem       Date:  2004-02-03       Impact factor: 5.157

Review 2.  Mechanisms of RNA-mediated disease.

Authors:  Jason R O'Rourke; Maurice S Swanson
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

Review 3.  Pathogenic mechanisms of myotonic dystrophy.

Authors:  Johanna E Lee; Thomas A Cooper
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

4.  Ectopic expression of CGG containing mRNA is neurotoxic in mammals.

Authors:  Vera Hashem; Jocelyn N Galloway; Mayra Mori; Rob Willemsen; Ben A Oostra; Richard Paylor; David L Nelson
Journal:  Hum Mol Genet       Date:  2009-04-18       Impact factor: 6.150

5.  Alternative splicing in disease and therapy.

Authors:  Mariano A Garcia-Blanco; Andrew P Baraniak; Erika L Lasda
Journal:  Nat Biotechnol       Date:  2004-05       Impact factor: 54.908

Review 6.  Pathogenic RNA repeats: an expanding role in genetic disease.

Authors:  Laura P W Ranum; John W Day
Journal:  Trends Genet       Date:  2004-10       Impact factor: 11.639

Review 7.  Rethinking ALS: the FUS about TDP-43.

Authors:  Clotilde Lagier-Tourenne; Don W Cleveland
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

8.  The neurofibromatosis type I pre-mRNA is a novel target of CELF protein-mediated splicing regulation.

Authors:  Victoria A Barron; Hui Zhu; Melissa N Hinman; Andrea N Ladd; Hua Lou
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

9.  Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3.

Authors:  Fiona M Menzies; Jeannette Huebener; Maurizio Renna; Michael Bonin; Olaf Riess; David C Rubinsztein
Journal:  Brain       Date:  2009-12-09       Impact factor: 13.501

Review 10.  RNA and disease.

Authors:  Thomas A Cooper; Lili Wan; Gideon Dreyfuss
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

View more
  17 in total

Review 1.  Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Curr Opin Genet Dev       Date:  2011-04-13       Impact factor: 5.578

Review 2.  Networking in a global world: establishing functional connections between neural splicing regulators and their target transcripts.

Authors:  John A Calarco; Mei Zhen; Benjamin J Blencowe
Journal:  RNA       Date:  2011-03-17       Impact factor: 4.942

Review 3.  Dysregulation of mRNA Localization and Translation in Genetic Disease.

Authors:  Eric T Wang; J Matthew Taliaferro; Ji-Ann Lee; Indulekha P Sudhakaran; Wilfried Rossoll; Christina Gross; Kathryn R Moss; Gary J Bassell
Journal:  J Neurosci       Date:  2016-11-09       Impact factor: 6.167

Review 4.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

Review 5.  RNA-binding proteins, neural development and the addictions.

Authors:  C D Bryant; N Yazdani
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

6.  The expression analysis of Sfrs10 and Celf4 during mouse retinal development.

Authors:  Devi Krishna Priya Karunakaran; Sean Congdon; Thomas Guerrette; Abdul Rouf Banday; Christopher Lemoine; Nisarg Chhaya; Rahul Kanadia
Journal:  Gene Expr Patterns       Date:  2013-08-07       Impact factor: 1.224

7.  Position-dependent and neuron-specific splicing regulation by the CELF family RNA-binding protein UNC-75 in Caenorhabditis elegans.

Authors:  Hidehito Kuroyanagi; Yohei Watanabe; Yutaka Suzuki; Masatoshi Hagiwara
Journal:  Nucleic Acids Res       Date:  2013-02-14       Impact factor: 16.971

8.  Development of GMDR-GPU for gene-gene interaction analysis and its application to WTCCC GWAS data for type 2 diabetes.

Authors:  Zhixiang Zhu; Xiaoran Tong; Zhihong Zhu; Meimei Liang; Wenyan Cui; Kunkai Su; Ming D Li; Jun Zhu
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

9.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

10.  Structural disorder and the loss of RNA homeostasis in aging and neurodegenerative disease.

Authors:  Douglas A Gray; John Woulfe
Journal:  Front Genet       Date:  2013-08-14       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.